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ABSTRACT 
Objective: The hypoxia inducible factor (HIF)-1 pathway signalling has a protective 
effect against ischemia/reperfusion injury. The prolyl-hydroxylase inhibitor 
Dimethyloxalylglycine (DMOG) activates the HIF-1 pathway by stabilizing HIF-1. In 
a rat model of brain death (BD)-associated donor heart dysfunction we tested the 
hypothesis that a pre-treatment of brain-dead donors with DMOG results in a better 
graft heart condition. 
Methods: BD was induced in anaesthetized Lewis rats by inflating a subdurally 
placed balloon catheter. Controls were sham-operated. Then, rats were injected with 
a single dose of DMOG (30mg/kg i.v.) or an equal volume of physiological saline. 
After 5h of BD or sham-operation, hearts were perfused with a cold (4°C) 
preservation solution (Custodiol), explanted, stored at 4°C Custodiol and 
heterotopically transplanted. Graft function was evaluated 1.5h after transplantation. 
Results: Compared to control, BD was associated with decreased left-ventricular 
systolic and diastolic function. DMOG treatment after BD improved contractility 
(ESPVR E'max: 3.7±0.6 vs 3.1±0.5 mmHg/µl; p<0.05) and left-ventricular stiffness 
(EDPVR: 0.13±0.03 vs 0.31±0.06 mmHg/µl; p<0.05) 5 hours later compared to brain-
dead group. Following heart transplantation, DMOG treatment of brain-dead donors: 
significantly improved the altered systolic function; decreased inflammatory 
infiltration; decreased cardiomyocyte necrosis and DNA-strand breakage. 
Additionally, compared to brain-dead group, DMOG treatment moderated the pro-
apoptotic changes in the gene and protein expression. 
Conclusions: In a rat model of potential brain-dead heart donors, pre-treatment with 
DMOG resulted in improved early recovery of graft function after transplantation. 
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These results support the hypothesis that activation of the HIF-1 pathway has a 
protective role against BD-associated cardiac dysfunction. 
INTRODUCTION 
Heart transplantation is the gold standard treatment of end-stage heart failure, 
presenting excellent results on both short and long term basis [1]. The main limiting 
factor of organ donation is the availability of suitable organs, meanwhile donor pool is 
limited to brain-dead donors. Though optimal myocardial preservation is a 
prerequisite to preserve early allograft function, brain death (BD) itself appears to 
induce severe changes on the heart function to such an extent, that potential donors 
must be excluded from transplantation because of emerging hemodynamic instability 
and primary cardiac dysfunction [2, 3]. Herniation of the brain stem induces a 
catecholamine storm with an extreme circulatory load, followed by neurohormonal 
dysfunction with a rapid loss of vasomotoric tone [4]. Abrupt vasodilatation due to 
circulatory regulational disturbances causes a prominent reduction of coronary blood 
flow and may result in ischemic injury of the donor heart [5, 6]. The ischemic period 
activates the hypoxia pathway of the cells via the hypoxia inducible factor (HIF)-1 and 
its subsequent target genes, such as heme oxygenase (HO)-1, glucose transporter 
(GLUT)-1, and vascular endothelial growth factor (VEGF). As a result, substrates and 
enzymes for the anaerobe metabolism are provided, and cell survival is ensured. 
HIF-1 plays a key role in the regulation of genes responsible for hypoxia adaptation. 
Though its role in different cellular mechanisms (apoptosis, autophagy) is not yet fully 
revealed, the activation of HIF-1 improves the ischemic injury of cardiac cells in cell 
culture [7], and attenuates myocardial ischemia/reperfusion (I/R) injury [8, 9]. 
Hearts from brain-dead donors exposed to an ischemic event additionally to the 
transplantational I/R injury, experience a more intense inflammatory response, 
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including the production of cytokines and reactive oxygen and nitrogen species 
(ROS/RNS), causing endothelial cell dysfunction, disturbance in graft 
microcirculation, neutrophil extravasation induced inflammatory cascade activation, 
thus leading to parenchymal tissue damage in the graft [10-12] and ultimately to an 
increased rate of graft rejection. 
Prolyl-4 hydroxylases (PHDs) act as cellular oxygen sensors, and they are the main 
regulators of (HIF) -1 heterodimer availability. They are responsible for the post-
translational HIF-1 hydroxylation under normoxigenic conditions, by targeting the 
subunit for the von Hippel Lindau tumor suppressor protein E3 ubiquitin ligase 
complex, thus leading to the degradation of HIF-1 (Figure 1) [13]. 
Dimethyloxallylglycine (DMOG) is the non-selective inhibitor of PHDs. Based on the 
previously described relations, the aim of the present study was to test the 
hypothesis that PHD inhibition, by a single dose of DMOG treatment in brain-dead 
donor rats improves in vivo left ventricular (LV) graft function after a heart 
transplantation, using our well established model [10, 14]. 
METHODS 
See online supplement for further details. 
1. Animals 
Male Lewis rats (250-350g; Charles River, Sulzfeld, Germany) were housed in a 
room at a constant temperature of 22±2ºC with 12h light/dark cycles and were fed a 
standard laboratory rat diet with water ad libitum. All animals were cared for in 
compliance with the ‘Principles of Laboratory Animal Care’ determined by the 
National Society for Medical Research and the ‘Guide for the Care and Use of 
Laboratory Animals’ prepared by the Institute of Laboratory Animal Resources and 
published by the National Institutes of Health (NIH Publication No. 86-23, revised 
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1996) and the German animal protection code. Approval was also granted by the 
appropriate ethics review board (G-59/14). 
 
2. Experimental groups and timeline 
Following a baseline hemodynamic measurement, rats were randomly assigned to 
three groups: (1) Control group (n=11): sham operated animals without BD induction; 
(2) Brain-dead group (n=7): after BD induction rats were injected with a vehicle 
(1ml/kg i.v. physiologic saline); (3) Brain-dead+DMOG group (n=7): after BD 
induction rats were injected with DMOG (30mg/kg; 1ml/kg i.v.). The experimental 
protocol is shown in Figure 2. Hemodynamic measurements were performed before 
BD induction, after the induction phase at T=0h and 5 hours later at T=5h. The hearts 
were then perfused with a cold (4°C) preservation solution (Custodiol), explanted, 
stored at 4°C Custodiol and then heterotopically transplanted with an ischemic time 
adjusted to 1h. The LV function was measured after a reperfusion time standardized 
to 1.5h. The dose of DMOG was chosen on the basis of our pilot studies and data 
from literature [9, 15, 16].  
 
3. Model of Brain Death 
After being anesthetized with sodium pentobarbital (60mg/kg, intraperitoneally), the 
rats were endotracheally intubated and ventilated by a rodent respirator. For the 
continuous measurement of arterial pressure, a 2F Millar microtip pressure-volume 
catheter (SPR-838, Millar Instruments, Houston, TX, USA) was inserted into the right 
carotid artery. For volume administration purposes, a central venous catheter was 
inserted into the jugular vein. A small 4F hole was drilled to the bregma, and a 
balloon catheter was introduced subdurally. BD was induction through gradual 
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increase in intracranial pressure by inflating the previously inserted balloon with 15µl 
saline per minute, until a total volume of 750µl was reached. The state of BD was 
confirmed 30 min after the onset of BD, by the absence of corneal reflexes and a 
positive apnea test. The blood pressure was maintained through volume 
administration without inotropic or vasoactive agents. Rats with induced BD and 
control animals (without BD) were maintained and monitored for 5h. 
 
4. Hemodynamic measurements before, and 5h hours after, sham-
operation or brain death induction 
In order to assess cardiac function at baseline condition and 5h after the induction of 
BD, the 2F pressure-volume conductance catheter (Millar Instruments, Houston, TX, 
USA) was advanced into the left-ventricle. With the use of a special pressure-volume 
analysis program (PVAN, Millar Instruments, Houston, TX, USA), heart rate, mean 
arterial pressure, LV end-systolic pressure, LV end-diastolic pressure, LV end-
systolic volume, LV end-diastolic volume, stroke volume (SV), maximum rate of rise 
of LV pressure (dP/dtmax), maximum rate of fall of LV pressure (dP/dtmin), and the 
ejection fraction were calculated. Ventricular relaxation was assessed by the time 
constant of LV pressure decay (Tau), and was calculated using the Glantz method 
(Tau-g; regression of dP/dt versus pressure). LV pressure-volume relations were 
measured by transiently occluding the inferior vena cava (reducing preload) under 
the diaphragm with a cotton-tipped applicator. The slope of the end-systolic pressure-
volume relationship (Emax; according to the parabolic curvilinear model [17]) was 
calculated as a load-independent index of LV contractility. The slope of the end-
diastolic pressure-volume relationship (EDPVR) was calculated as a reliable index of 
LV stiffness. At the end of each experiment, 0.1 ml hypertonic saline were injected 
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into the jugular vein, and from the shift of the pressure-volume relations, the parallel 
conductance volume was calculated using the software mentioned above. The waws 
used to correct the cardiac mass volume. After completing the hemodynamic 
measurements, blood samples were collected from the inferior vena cava. The 
volume calibration of the conductance system was performed as previously 
described [18]. 
 
5. Model of Heterotopic Heart Transplantation 
The transplantations, as previously described [10], were performed in isogenic Lewis 
to Lewis rat strain, therefore no organ rejection could be expected. The superior and 
inferior caval veins and the pulmonary veins were tied en masse with a suture and 
the heart was immediately placed into cold (4ºC) Custodiol solution [19, 20]. The 
aorta and the pulmonary artery of the donor heart were correspondingly 
anastomosed end to side to the abdominal aorta and the vena cava of the recipient 
rat. The ischemic time was adjusted to 1h. After completion of the anastomoses, the 
heart was reperfused with blood in situ, and the reperfusion time was standardized to 
1.5h. 
 
6. Measurement of Left-Ventricular Function of the Graft 
One and a half hours after transplantation, a 3F latex balloon catheter (Edwards 
Lifesciences Corporation, Irvine, CA, USA) was introduced into the left-ventricle via 
the apex to determine LV systolic pressure, LV diastolic pressure, dP/dtmax and 
dP/dtmin by a Millar micromanometer (Millar Instruments, Houston, TX, USA) at 
different LV volumes. From this data, LV pressure-volume relationships were 
constructed. 
	
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7. Histopathological Process 
Heart samples from each experimental group were fixed in buffered 
paraformaldehyde solution (4%) and embedded in paraffin. Then, 5-m-thick 
sections were placed on adhesive slides. Morphometric analysis was performed for 
inflammation and necrosis on hematoxylin and eosin stained sections. The evaluation 
was conducted by an investigator blinded to the experimental groups. The evaluation 
was performed by scoring according to the grade 0-3 under a light optical microscope 
with nine or ten sections from each sample.  
 
8. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling 
(TUNEL) staining 
TUNEL staining was performed to detect DNA-strand breaks in the myocardial cells 
of the left ventricle. TUNEL-positive cells were counted in four fields (characterizing 
each specimen) under a fluorescence microscope, and an average value was 
calculated for each experimental group. The evaluation was conducted by an 
investigator blinded to the experimental groups. Mean values were calculated again 
for each experimental group, and then were compared. 
 
9. Quantitative Real-Time Polymerase Chain-Reaction (PCR) 
Total RNA was isolated from the grafts hearts and then reverse transcription was 
performed. Quantitative real-time PCR was completed on the LightCycler480 system 
with the LightCycler480 Probes Master and Universal ProbeLibrary probes (Roche, 
Mannheim, Germany). Efficiency of the PCR reaction was confirmed with standard 
curve analysis. Every sample was quantified in duplicate and normalized to 
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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. The expression 
of HIF-1 and its target genes [HO-1, GLUT-1, VEGF], along with caspase-3, Bcl-2, 
Nuclear factror (NF)- and Tumor necrosis factor (TNF)- was determined. Results 
form every group were illustrated as normalised to the sham-operated control values. 
For detailed description see online supplementary data and Online Table 1. 
 
10. Western Blotting 
Myocardial protein expression of HIF-1, HO-1 (1:2000, Abcam, Cambridge, UK), 
GLUT-1 (1:200, Abcam, Cambridge, UK), cleaved caspase-3 (1:100, NeoMarkers, 
Fremont CA, USA), and loading control GAPDH (1:500, Santa Cruz Biothechnology, 
Heidelberg, Germany) was measured by western blot. Results form every group were 
illustrated as normalised to the sham-operated control values. 
 
11. Statistical analysis 
All data is tested for normality (Shapiro-Wilk) and expressed as mean ± standard 
error of the mean (SEM). Intergroup comparisons were performed by using one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test. Differences were 
considered significant when p<0.05. 
RESULTS 
LV Cardiac function of donor hearts after brain death 
Before the induction of BD (baseline conditions) no significant difference was 
measured in the hemodynamic parameters of the different groups (data not shown). 
Mean arterial pressure showed a constant decrease in both brain-dead groups 
(Figure 3A). Compared either to its baseline or to control group, 5 hours of BD was 
associated with significantly decreased systolic performance and with an impaired 
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cardiac relaxation. DMOG treatment significantly increased the load-independent 
contractility parameter (E'max) and improved LV stiffness (slope of EDPVR) of the 
hearts of brain-dead donors, compared to the untreated brain-dead group (Table 1). 
 
LV function of the heart grafts 
Significantly decreased LV systolic pressure, developed LV pressure and dP/dtmax 
were found in both brain-dead groups, when compared to the control rats, indicating 
decreased systolic function, which was significantly improved by DMOG treatment 
(Figures 3B, C, D). Compared to control, impaired ventricular relaxation was 
observed in hearts from brain-dead donors. DMOG treatment led to significantly 
increased dP/dtmin and to a lower Tau index (Figures 3E, F). LV end-diastolic 
pressure, as a marker of the standardized balloon-catheter measurements (data not 
shown) did not show a major difference amongst the experimental groups.  
 
Inflammatory changes of the heart grafts 
Semiquantitative histological analysis of the tissue sections revealed a slight 
infiltration of inflammatory cells, rare necrosis and mild edema in the control group. 
Similar results were found in the heart grafts after DMOG treatment, while in contrast, 
extensive inflammation with marked inflammatory cell infiltration, and necrosis were 
seen in the brain-dead group (Figures 4A-E). A significant up-regulation of 
transcription factors NF-kB and TNF- was detected in the brain-dead group when 
compared to the control group. DMOG treatment significantly decreased the up-
regulation of these factors (Figures 4F, G). 
 
DNA-strand breaks and expression of apoptotic factors in the heart-grafts 
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Increased rate of TUNEL-positive cell nuclei (containing red fluorescent nuclei 
indicating DNA-fragmentation) was detected in the myocardium of grafts from brain-
dead donors when compared to control animals. However, brain-dead donors treated 
with DMOG were not significantly different from control rats (Figures 5D). In relation 
to the pro- and anti-apoptotic genes, BD caused a significant up-regulation of 
caspase-3 and down-regulation of Bcl-2 compared to control, meanwhile DMOG 
treatment resulted in a significantly lower caspase-3 expression and higher Bcl-2 
expression, compared to the brain-dead group (Figures 5E, F). Western-blot 
analysis of the cleaved caspase-3 levels also supported the results found by 
quantitative real-time PCR (Figure 5G). 
 
Expressional analysis of the HIF-1 pathway in the heart grafts 
Quantitative real-time PCR revealed an up-regulation of the HIF-1 mRNA 
expression in both groups with BD compared to control group, but it only reached a 
significant level in the DMOG-treated brain-dead group. In the expression of the HIF 
target genes HO-1, GLUT-1, and VEGF no difference was observed in the brain-
dead group versus the control group, but a considerable up-regulation of these genes 
was detected after DMOG treatment. Compared to control, BD did not alter the 
protein levels of HIF-1, DMOG treatment caused a 3-fold increase in it. 
Densitometric analysis of the HO-1 bands showed a significant 1.9 fold increase in 
the brain-dead group compared to control, DMOG treatment further increased its 
level to 2.5 fold. GLUT-1 protein expression was significantly increased by DMOG 
treatment, in comparison to control and brain-dead groups (Figures 6A-H). 
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DISCUSSION 
In this study the beneficial effect of DMOG pre-treatment against global I/R injury was 
assessed through a rat model of heterotopic cardiac transplantation using heart 
grafts from brain-dead donors. 
Experimental models demonstrate the widely discussed pathophysiologic 
consequences of BD [5, 21] and discuss the possible underlying mechanisms, such 
as catecholamine storm during Cushing-reaction, followed by arterial spasm causing 
insufficient blood perfusion, or hormonal depletion with abrupt vasodilatation and 
sudden drop of aortic and coronary blood-pressure [22-25]. In agreement with these 
findings and in spite of the regularly injected volume, in five hours run MAP 
significantly decreased along with the LV pressures and load dependent contractility 
parameters in the brain-dead group (Table 1). Studies even revealed BD induced 
systemic inflammatory reaction with inflammatory cytokine expression [2, 26]. By 
these mechanisms BD increases the susceptibility of donor hearts to 
transplantational I/R injury, and is associated with increased acute rejection rates 
when the graft organs are derived from brain-dead donor animals [27]. 
During I/R injury pathologic levels of hypochlorus-acid and peroxynitrite form 
activated leukocytes cause DNA strand breakage, mitochondrial function disruption, 
lipid peroxidation induction and depletion of antioxidant reserve, thus activating the 
apoptotic cascade [28, 29]. Pharmacological preconditioning of cells by the inhibition 
of oxygen sensors could be a promising strategy against ischemic and inflammatory 
diseases. The non-selective PHD inhibitor DMOG was previously shown to have 
advantageous effect against I/R injury in animal models of myocardial infarction [9, 
30], and we have recently also reported about the protective effect of DMOG in in 
vitro vascular function after long term (24h) cold preservation and reperfusion injury 
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[7]. In their recent publication Keränen et al. described enhanced I/R damage of the 
graft hearts following HIF activation. This conclusion was drawn from increased 
cardiac troponin T release and increased inflammatory response in an I/R model 
following preconditioning of heart donors with PHD inhibitor FG-4497 [31]. Although 
they did not examine the hemodynamic performance of heart grafts, the contradiction 
in the results compared to our findings may lay in the different experimental setup 
and in the different ischemic / reperfusional time intervals. 
DMOG pre-treatment of brain-dead donors did not hinder the BD-caused decrease of 
MAP along with the LV pressures and load dependent contractility parameters in 5h. 
However, our results show a maintained E'max of ESPVR in the DMOG group, 
compared to brain-dead group (Table 1). After hypothermic storage and 1.5 hours of 
reperfusion transplanted hearts from brain-dead donors showed significantly lower 
contractility and relaxation, which was significantly improved by DMOG pre-treatment 
(Figure 3). In line with these observations increased DNA strand breakage, up-
regulated caspase-3 and TNF with down-regulated Bcl-2 levels were detected in 
graft hearts from brain-dead donors following transplantation (caused by the nocuous 
effect of BD and by the additional I/R injury during transplantation). These changes 
were moderated due to the advantageous effect of DMOG in the pre-treated group 
(Figures 4-5). 
The mechanisms behind the cardioprotective effects of DMOG against I/R injury are 
based on the inhibition of the oxygen-sensor PHDs (Figure 1). In the absence of 
oxygen, PHDs are no longer active and the unmodified HIF-1 accumulates. 
Dimerising with the constitutive HIF-1 (also known as aryl hydrocarbon receptor 
nuclear translocator: ARNT), they form HIF-1 heterodimer (a transcription factor of 
genes participating in tissue response to hypoxia [32]), which limits ischemic or post-
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ischemic injury (HO-1, GLUT-1, VEGF, iNOS) [8]. After transplantation, brain-dead 
donors treated with DMOG showed a significant up-regulation of HIF-1 expression 
compared to the control group. We also found an up-regulation of HIF-1 mRNA after 
DMOG treatment compared to control group. However, as there was no difference 
found when compared to the brain-dead group, this increase could be accounted to 
the circulatory insufficiency due to BD. 
HO-1 overexpression in cardiac tissue leads to a lower apoptosis rate after I/R [33], 
possible due to its products CO and biliverdin: both of them have been proved to 
ameliorate I/R injury [34]. GLUT-1 overexpression protected cardiac myocytes from 
hypoxia induced apoptosis via mitochondrial release of cytochrome c and activation 
of caspase 9 [35, 36]. VEGF acts as a survival factor along with its long term capillary 
promoting effect, and in short term decreases the loss of viability, under hypoxic 
conditions [37, 38]. We confirmed marked up-regulation of these HIF-1 induced 
protective factors after DMOG treatment (Figures 6). 
Expressional changes after the activation of the HIF-pathway during 5 hours 
incubation contribute to decreased myocardial vulnerability either caused by the 
damaging effect of BD, or by I/R injury during transplantation. Following these insults, 
TUNEL is a sensitive method for the assessment of oxidative stress-caused DNA 
damage. As shown on Figure 5, after DMOG pre-conditioning, the lower level of 
double strand DNA fragmentation is in correlation with the expressional changes in 
caspase-3 pro- and Bcl-2 anti-apoptotic regulators. From this correlation we conclude 
a significantly lower apoptotic activity following DMOG pre-treatment compared to 
that of the brain-dead group. 
The silencing of PHDs augments NF-B activation [39]. Although NF-B was 
described to protect myocytes against ischemia-induced apoptosis in a HIF 
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independent manner by the up-regulation of TNF [40], NF-B and TNF also facilitate 
inflammatory reactions. Under mild hypoxia phosphoinositide-3 kinase/Akt pathway 
prevents the inhibition of the anti-apoptotic Bcl-xL and induces NF-B thus leading to 
cell survival [41]. A significant up-regulation of NF-B and TNF mRNA were 
detected along with increased infiltration of inflammatory cells in the brain-dead group 
compared to control and DMOG. 
All together, in clinical perspective DMOG treatment may have advantegous effect 
under brain-dead state, protecting against the ischemic events and inflammation-
caused oxidative load. On the other hand, DMOG pre-conditioning a couple of hours 
before transplantation could improve early post-transplantational graft-function. 
 
Conclusions 
To the best of our knowledge, our study is the first that records the cardioprotective 
effect of a pharmacological preconditioning with dimethyloxalylglycine on the donor 
heart function under BD conditions, and on the LV graft function after transplantation. 
The treatment of brain-dead heart donors with DMOG resulted in a significantly better 
left-ventricular function after the transplantation. All in all, our results support the view 
that preconditioning through the inhibition of oxygen sensors, and through the 
activation of HIF-1 pathway is, potentially, at least in part, associated with a 
protective role against I/R injury in the myocardium. 
 
 
 
 


Study limitations 
The model of heterotopic heart transplantation also has certain limitations. The left-
ventricle beats in an unloaded condition (e.g. ventricles are perfused via the coronary 
circulation, but they do not eject) which on one hand allows a faster recovery after 
transplantation, and on the other hand leads to a time-dependent mechanical 
deterioration and atrophy (though it does not occur in 24h) [42]. The influence of 
prolonged anesthesia on the donor cardiac function shall also be considered a 
limitation of the model of BD as it deviates from the clinical setting of most donors. 
The brief period of reperfusion (1.5 hrs) limits conclusions regarding the effects of 
DMOG to early recovery of donor function from BD-associated and I/R-induced 
injuries. Prudent interpretation of the findings obtained from this animal model is 
required for the extrapolation to humans.
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Table 1.: Cardiac hemodynamic parameters of donors 5h after sham operation 
or induction of brain death 
MAP: mean arterial pressure, LVESP: left-ventricular end-systolic pressure; LVEDP: 
left-ventricular end-diastolic pressure, dP/dtmax: maximum rate of rise of LV pressure, 
dP/dtmin: maximum rate of fall of LV pressure, LVESV: left-ventricular end-systolic 
Parameters Control 
donors 
Brain-dead 
donors 
Brain-
dead+DMOG 
donors 
Heart rate (beats/min) 384±15 351±19  372±21 
MAP (mmHg) 95±5 51±3* 48±5* 
LVESP (mmHg) 109±6 57±6* 64±7* 
LVEDP (mmHg) 9±2 6±1* 4±1* 
Ejection fraction (%) 42±5 25±5* 26±4* 
dP/dtmax (mmHg/s) 7940±765 3418±560* 3086±418* 
dP/dtmin (mmHg/s) 10396±663 3121±328* 3138±860* 
LVESV (µl) 58±19 115 ±28* 105±22* 
LVEDV (µl) 83±18 146±29* 136±22* 
Stroke Volume (µl) 40±4 36±8 35±5 
ESPVR E'max (mmHg/µl) 3.5±0.4 3.1±0.5 3.7±0.6# 
Tau-g (ms) 10±0.5 15±6 15±4 
Slope of EDPVR 
(mmHg/µl) 
0.112±0.02 0.301±0.06* 0.128±0.03# 


volume, LVEDV: left-ventricular end-diastolic volume, EDPVR: end-diastolic pressure 
volume relationships. All values are expressed as mean±SEM. *p<0.05 versus 
Control, #p<0.05 versus BD. 
Figure 1. The HIF-pathway and the role of DMOG 
HIF: Hypoxia Inducible Factor; PHDs: members of Prolyl-Hydorxilase family; OH: 
hydoxil-group and pVHL: Von Hippel-Lindau protein. 
 
Figure 2. Experimental protocol 
Hemodynamic functional measurements were performed before BD induction 
(baseline), after confirmation of BD or after sham-operation with injection of Saline or 
DMOG at T=0 hours, and at T=5 hours after BD induction. The left-ventricular 
function of the graft hearts was measured 1.5 hours after the initiation of reperfusion.  
Figure 3. Mean arterial pressure during brain-dead state (A) and 
Left-ventricular function of the graft hearts after transplantation (B-F) 
(A) Mean arterial pressure volumes during the 5 hours of BD (B) Left-ventricular end-
systolic pressure - left-ventricular volume (LVESP); (C) Left-ventricular (LV) 
developed pressure; (D) Change of mean arterial pressure during BD; (E) maximum 
rate of rise of left-ventricular pressure (dP/dtmax); (F) maximum rate of fall of LV 
pressure (dP/dtmin) and (F) time constant of LV pressure decay (Tau-W) at an 
intraventricular volume of 120 µl. Measurements were performed after 1.5 hours of 
reperfusion. *p<0.05 versus Control, #p<0.05 versus BD. 
 
 
 


Figure 4. Histopathological and expressional analysis of inflammation and 
necrosis in the graft hearts after transplantation 
Representative photomicrographs of hematoxylin-eosin stained sections (A-C) 
(magnification x100; scale bar: 100 µm) along with the semiquantitative scoring of 
myocardial (D) inflammation, (E) necrosis. 
Quantitative real-time PCR analysis of myocardial mRNA levels of (F) Nuclear Factor 
(NF)-kappa , (G) Tumor Necrosis Factor (TNF)-. *p<0.05 versus Control, #p<0.05 
versus BD. 
Figure 5. DNA-strand breaks and expression of apoptotic factors in graft hearts 
after transplantation 
The rate of TUNEL positive cells in each experimental group (A), quantitative real-
time PCR analysis of myocardial mRNA levels of (B) caspase-3, (C) B-cell 
CLL/lymphoma 2 (Bcl-2), and densitometric analysis of bands for (D) cleaved 
caspase 3. *p<0.05 versus Control, #p<0.05 versus BD. 
Representative photomicrograms of cardiomyocytes stained with (E) 4', 6-diamino-2-
phenylindole (DAPI, blue), (F) nuclei with fragmented DNA visualized by TUNEL 
staining (red), and (G) merged image (magnification x400; scale bar: 20 µm). 
Figure 6. mRNA and protein expression analysis of the HIF pathway in the graft 
hearts after transplantation 
Quantitative real-time PCR analysis of myocardial mRNA levels (above) and 
densitometric analysis of bands (below) for (A-B) Hypoxia Inducible Factor (HIF)-1 
alpha, (C-D) Heme-oxygenase (HO)-1, (E-F) Glucose Transporter (GLUT)-1, (G-H) 
Vascular Endothelial Growth Factor (VEGF). *p<0.05 versus Control, #p<0.05 versus 
BD. 
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